Hongwei Wang

7.5k citations
167 papers · 4.4k indexed · h-index 37
Topics
RNA modifications and cancer (27 papers)Cancer-related molecular mechanisms research (25 papers)RNA Research and Splicing (17 papers)

In The Last Decade

Hongwei Wang

159 papers receiving 4.4k citations

Peers

Hongwei Wang
Comparison fields: 5 of 143
  • Molecular Biology 2.1k
  • Cancer Research 1.0k
  • Epidemiology 785
  • Oncology 745
  • Surgery 576
Replace Aloysius J. Klingelhutz with:
Aloysius J. Klingelhutz United States
Susanne I. Wells United States
Kathleen T. Montone United States
Yoshitaka Okamoto Japan
Thomas Löning Germany
M. Duchrow Germany
Ulrich Schwab United Kingdom
David A. Levison United Kingdom
Jörn Bullerdiek Germany
Tomokazu Yoshizaki Japan
Hongwei Wang relative to Aloysius J. Klingelhutz United States Aloysius J. Klingelhutz's profile →
Citations per field
00.5×1.5×1.8×
Aloysius J. Klingelhutz · 1×
Citations per year

Countries citing papers authored by Hongwei Wang

Since Specialization
Citations

This map shows the geographic impact of Hongwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Wang more than expected).

Fields of papers citing papers by Hongwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Wang. The network helps show where Hongwei Wang may publish in the future.

Co-authorship network of co-authors of Hongwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Wang. A scholar is included among the top collaborators of Hongwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Wang. Hongwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 2
5 2
6 2
7 38
8 47
9 7
10 38
11 23
12 8
13 33
14 43
15 92
16 65
17 45
18 15
19 24
20 10

About Hongwei Wang

Hongwei Wang is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 167 papers that have together received 4.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (27 papers), Cancer-related molecular mechanisms research (25 papers) and RNA Research and Splicing (17 papers). The work is most often cited by research in Cancer Research (1.0k citations), Otorhinolaryngology (225 citations) and Molecular Biology (2.1k citations). Hongwei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhi Xie, Jürgen Schwarze, N. Peters, Zheng Guo, Yunyan Gu, John D. Carpten, Gregory D. Jay, Wenyuan Zhao, Matthew L. Warman and Yuling Luo. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026